|
gptkbp:instanceOf
|
antipsychotic medication
benzamide derivative
|
|
gptkbp:approvedBy
|
gptkb:Asia
gptkb:Europe
|
|
gptkbp:ATCCode
|
N05AL01
|
|
gptkbp:brand
|
Dogmatil
Sulpor
|
|
gptkbp:CASNumber
|
15676-16-1
|
|
gptkbp:category
|
antidepressant
antiemetic
typical antipsychotic
dopamine antagonist
prolactin releaser
|
|
gptkbp:compatibleWith
|
gptkb:United_States
|
|
gptkbp:contraindication
|
gptkb:pheochromocytoma
prolactin-dependent tumors
|
|
gptkbp:discoveredBy
|
Laboratoires Delagrange
|
|
gptkbp:eliminationHalfLife
|
6-8 hours
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:firstMarketedYear
|
1967
|
|
gptkbp:has_stereochemistry
|
racemic mixture
|
|
gptkbp:hasMolecularFormula
|
C15H23N3O4S
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
sulpiride
|
|
gptkbp:KEGGID
|
D01219
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:France
|
|
gptkbp:mechanismOfAction
|
dopamine D2 receptor antagonist
|
|
gptkbp:MeSH_ID
|
D013438
|
|
gptkbp:metabolism
|
minimal hepatic
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
5375
5183
CHEMBL1407
DB00391
|
|
gptkbp:relatedTo
|
gptkb:amisulpride
tiapride
levosulpiride
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
|
|
gptkbp:sideEffect
|
gptkb:hyperprolactinemia
weight gain
insomnia
drowsiness
extrapyramidal symptoms
gastrointestinal disturbances
|
|
gptkbp:synonym
|
Sulpirida
Sulpiridum
|
|
gptkbp:UNII
|
U42B7VYA4P
|
|
gptkbp:usedFor
|
gptkb:depression
schizophrenia
anxiety disorders
vertigo
|
|
gptkbp:bfsParent
|
gptkb:N05AX
|
|
gptkbp:bfsLayer
|
7
|